Cannabis Use Disorder Treatment in 2026: Risks, Psychosis, and New Treatment Standards
By Vero Beach Recovery Center Clinical Team | Medically Reviewed | March 2026
March 2026
Cannabis use disorder (CUD) is becoming more common as high-potency THC products, including vapes, concentrates, and edibles, become more widely available. As cannabis potency rises, so does the risk of dependence, impaired functioning, psychosis, and co-occurring mental health conditions.
What Is Cannabis Use Disorder (CUD)?
Cannabis use disorder is a clinical condition recognized in the DSM-5. It involves a pattern of cannabis use that leads to significant impairment, loss of control, cravings, tolerance, withdrawal, and continued use despite negative consequences at work, school, home, or in relationships.
Why Cannabis Use Disorder Is Increasing
- Higher THC potency in modern cannabis products
- Increased use of vapes, edibles, and concentrates
- Greater social normalization and legalization
- Lower perceived risk among teens and young adults
Psychosis and Mental Health Risks
High-potency THC has been associated with cannabis-induced psychosis, paranoia, mood instability, and worsening symptoms in individuals vulnerable to schizophrenia spectrum disorders or bipolar disorder. Adolescents and young adults may be especially at risk when cannabis use begins early or becomes frequent.
Signs and Symptoms of Cannabis Addiction
- Cravings or strong urges to use cannabis
- Difficulty cutting down or stopping
- Using more than intended
- Loss of motivation or decline in daily functioning
- Continued use despite anxiety, paranoia, or depression
- Withdrawal symptoms such as irritability, insomnia, or restlessness
When Inpatient Treatment May Be Necessary
Inpatient or residential treatment may be appropriate when cannabis use contributes to severe impairment, repeated relapse, psychotic symptoms, unsafe behavior, or significant co-occurring mental health issues. A structured setting can provide stabilization, psychiatric support, and intensive therapy.
New Treatment Standards for 2026
There are currently no FDA-approved medications specifically for cannabis use disorder. The most effective treatment remains a combination of evidence-based behavioral therapies, including:
- Cognitive Behavioral Therapy (CBT)
- Motivational Enhancement Therapy (MET)
- Contingency Management
More clinicians are also screening for cannabis use during routine visits, especially for adolescents, young adults, and patients presenting with anxiety, depression, sleep disturbance, or psychotic symptoms.
Long-Term Effects of High-Potency THC
Long-term exposure to high-THC cannabis may affect memory, concentration, executive functioning, and emotional regulation. For some individuals, chronic use can worsen psychiatric symptoms and increase the need for dual diagnosis treatment.
Our Clinical Recommendations
Early intervention matters. Individuals with a family history of psychosis, schizophrenia, or severe mood disorders should be especially cautious with cannabis use. Screening, education, and timely treatment can reduce long-term harm and improve outcomes.
Get Help for Cannabis Use Disorder
If you or a loved one is struggling with cannabis dependence, relapse, or cannabis-related mental health symptoms, our clinical team can help. Our Intensive Outpatient Program (IOP) has provided evidence-based outpatient treatment to a wide variety of individuals needing help from CUD.
Frequently Asked Questions
Can cannabis cause psychosis?
Yes. High-potency THC has been linked to acute psychotic episodes, especially in adolescents and individuals with a genetic vulnerability to serious mental health disorders.
Is cannabis addictive?
Yes. Cannabis can be addictive, and cannabis use disorder is more likely in people who begin using young, use frequently, or consume high-potency products.
What is the best treatment for cannabis use disorder?
The most effective evidence-based treatments include cognitive behavioral therapy, motivational enhancement therapy, and contingency management.
Related Treatment Options
Sources & Clinical References
- National Institute on Drug Abuse (NIDA)
- JAMA Psychiatry research on cannabis and psychosis
- Centers for Disease Control and Prevention (CDC)
- DSM-5 diagnostic criteria for substance use disorders


